The
development of antibiotics to treat infectious diseases has
yielded profound benefits for human health. Pfizer has been
a leader in this field since becoming the first company in
the world to mass-produce penicillin in 1943. Despite the
great progress that has been made, infectious diseases have
proven to be formidable foes that still sicken or kill millions
of people every year.
|
 |
| |
 |
Zithromax is the number one oral antibiotic in its class worldwide. It treats most respiratory infections in adults and children with three-day regimens and once-daily dosing. Meanwhile, a single 1g dose of Zithromax can also provide successful efficacy for the treatment of STD (uncomplicated gonorrhea or chlamydia infections).
|
| |
|
|
 |
| |
 |
Sulperazon is unique combination of beta-lactamase inhibitor plus a third generation cephalosporin. It not only improves activity against increasing resistance pathogens producing beta-lactamases, but also expand antibacterial spectrum compared with other third generation cephalosporins.
|
| |
|
|
 |
| |
 |
Diflucan, the world's leading antifungal medicine, treats potentially life-threatening fungal infections that often afflict critically ill patients, because of its excellent efficacy and safety profile. It turns "early empiric therapy" into reality and has saved more patients' lives in their fight with invasive fungal infections.
|
| |
|
|
 |
| |
|
Cefobid, a third-generation cephalosporin, has been used widely in clinical practice and highly evaluated for its excellent characteristics. Cefobid has its distinguished features as broad-spectrum activity, higher blood concentration, strong penetration, unique elimination through bile and urine excretion, high efficacy and safety, convenient administration.
|
| |
|
|
 |
| |
|
Unasyn, a antibiotic to overcome bacterial resistance, restoring and extending its spectrum and reducing needs for combination antibiotic therapy. It is a good selection for mild to moderate infections.
|
| |
|
|
 |
| |
 |
Dalacin C is indicated in the treatment of intra-abdominal infections, gynecological infections, skin and soft tissue infections, bone and joint infections, upper and lower respiratory infections, septicemia and endocarditis, dental infections. It is also effective in the treatment of toxoplasmic encephalitis and pneumocystis carinii pneumonia in patients with AIDS.
|
| |
|
|
 |
| |
 |
Trobicin is indicated in the treatment of acute gonorrheal urethritis and proctitis in the male, and acute gonorrhea cervicitis and proctitis in the female.
|
| |
|
|
 |
| |
 |
Vfend, a new generation of azoles, a more potent and broader anti-fungal agent was developed on the base of fluconazole with strong clinical efficacy against Candida and Aspergillosis. Vfend has high brand awareness globally due to its proven efficacy, broader susceptibility, good safety and tolerance. During SARS period, Vfend
helped doctors to save SARS patients suffered from Aspergillosis, and Vfend will be considered to replace the golden standard role of Amphotericin B in the treatment of severe invasive fungal infection.
|
| |
|
|
 |
| |
 |
Zyvox is first antibacterial from a new structural class--Oxazolidinones and active against most clinically important Gram-positive bacteria1 (Staphylococcus aureus, Enterococci, streptococci)include MRSA and VRE. It demonstrates excellent penetration into fluids and tissues and effective on the treatment of Nosocomial pneumonia/Community-acquired pneumonia, skin and soft tissue infection and bacteremia. It is well tolerate with both injection and oral tablet which provide convenient administration.
|
| |
|
|
